About us
Profile
Contributors
Staff
Address
Contact Us
Articles
Canada
USA
International
Topics
Access to Medicines
Innovation
Comparative Effectiveness
Health Technology Assessment
Importation
Global Public Health
Emerging Markets
Patient Safety
Patient Advocacy
Events
Publications
Presentations
Reports and Research Papers
Register
Home
importation
1.
Importation and Issues in International Drug Pricing
2.
At least Two-Thirds of Foreign Drug Manufacturers that Export to the U.S. Have Never Been Inspected by the FDA
3.
Sales of Imported Drugs Drop 80 Percent as Americans Abandon Risky Drug Importation
4.
As lawmakers consider making it easier to import foreign drugs nearly two-thirds of Americans lack confidence in foreign manufactured prescription drugs
5.
Encouraging consumers to import foreign drugs puts american patients at risk
6.
H.H.S. report on drug importation concludes that there are significant risks associated with importing drugs for personal use
7.
Mail-order internet pharmacies in Canada cannot meet the needs of American consumers and may cause shortages for Canadian patients
8.
State-sanctioned drug importation websites demonstrate problems regulating quality, safety and patient privacy standards of foreign pharmacies
9.
State mail order importation schemes demonstrate the impact of product liability laws on American prescription drug prices
10.
Circumventing drug supply and distribution regulations to import prescription drugs puts patients at risk
<<
Start
<
Prev
1
2
Next
>
End
>>
Powered by
Tags for Joomla
Top Topics
access to medicines
canada
chronic disease
disease management
health policy
health spending
importation
innovation
patient safety
usa
Latest News
Gates Foundation donates $10 Billion in call for decade of vaccines
Chronic disease prevention and health promotion
Global partnerships facilitate access to medicines
Commentary re FT article - Neglected Diseases Less Neglected
WHO’s South East Asian Region (SEAR) May Not See Eye to Eye with WHO & EU on IP Rights
Popular Articles
Treatment of rare disorders: U.S and Europe enact legislation to encourage innovation and access while Canada lags behind
Case studies for global health
Global partnerships facilitate access to medicines
Accessing Drugs for Rare Diseases in Canada: The Patient Perspective
2008 UNAIDS report highlights decrease in global rate of infections; role of life-saving drugs
Social Media
Login
Username:
Password:
Remember Me
Forgot your password?
Forgot your username?
Create an account
Who's Online
We have
110 guests
online
Latest Events
No events
copyright © World Health Advocacy Inc.
